610 related articles for article (PubMed ID: 21749383)
1. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
[TBL] [Abstract][Full Text] [Related]
3. The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T
J Microencapsul; 2012; 29(3):211-8. PubMed ID: 22360765
[TBL] [Abstract][Full Text] [Related]
4. Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T
J Pharm Pharmacol; 2012 Mar; 64(3):353-9. PubMed ID: 22309267
[TBL] [Abstract][Full Text] [Related]
5. Effect of antioxidants on the stability of ONO-1301, a novel long-acting prostacyclin agonist, loaded in PLGA microspheres.
Uchida T; Hazekawa M; Morisaki T; Yoshida M; Sakai Y
J Microencapsul; 2013; 30(3):245-56. PubMed ID: 23094609
[TBL] [Abstract][Full Text] [Related]
6. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
10. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
Park W; Kim D; Kang HC; Bae YH; Na K
Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184
[TBL] [Abstract][Full Text] [Related]
11. Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats.
Obata H; Sakai Y; Ohnishi S; Takeshita S; Mori H; Kodama M; Kangawa K; Aizawa Y; Nagaya N
Am J Respir Crit Care Med; 2008 Jan; 177(2):195-201. PubMed ID: 17975203
[TBL] [Abstract][Full Text] [Related]
12. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
16. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
17. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
18. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
19. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]